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Abstract
Background: The spleen is a highly perfused organ involved in the immunological control and elimination of
vector-borne pathogens (VBP), which could have a fundamental role in the pathogenesis of splenic disease. This
study aimed to evaluate certain VBP in samples from dogs with splenic lesions.
Methods: Seventy-seven EDTA-blood and 64 splenic tissue samples were collected from 78 dogs with splenic
disease in a Mediterranean area. Babesia spp., Bartonella spp., Ehrlichia/Anaplasma spp., Hepatozoon canis,
Leishmania infantum, hemotropic Mycoplasma spp. and Rickettsia spp. were targeted using PCR assays. Sixty
EDTA-blood samples from dogs without evidence of splenic lesions were included as a control group.
Results: More than half (51.56%) of the biopsies (33/64) were consistent with benign lesions and 48.43% (31/64)
with malignancy, mostly hemangiosarcoma (25/31). PCR yielded positive results in 13 dogs with spleen alterations
(16.67%), for Babesia canis (n = 3), Babesia gibsoni (n = 2), hemotropic Mycoplasma spp. (n = 2), Rickettsia massiliae
(n = 1) and “Babesia vulpes” (n = 1), in blood; and for B. canis, B. gibsoni, Ehrlichia canis and L. infantum (n = 1 each),
in spleen. Two control dogs (3.3%) were positive for B. gibsoni and H. canis (n = 1 each). Benign lesions were
detected in the 61.54% of infected dogs (8/13); the remaining 38.46% were diagnosed with malignancies (5/13).
Infection was significantly associated to the presence of splenic disease (P = 0.013). There was no difference in the
prevalence of infection between dogs with benign and malignant splenic lesions (P = 0.69); however B. canis was
more prevalent in dogs with hemangiosarcoma (P = 0.006).
Conclusions: VBP infection could be involved in the pathogenesis of splenic disease. The immunological role of
the spleen could predispose to alterations of this organ in infected dogs. Interestingly, all dogs with B. canis
infection were diagnosed with hemangiosarcoma in the present survey. As previously reported, results support that
VBP diagnosis could be improved by analysis of samples from different tissues. The sample size included here
warrants further investigation.
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Background
Vector-borne pathogens (VBP) are arthropod-transmitted
agents, mainly parasites and bacteria, which cause a signifi-
cant impact on the health of dogs. In addition to their
veterinary importance, dogs can act as reservoirs for VBP
of major zoonotic concern [1]. The risks of canine vector-
borne diseases (CVBD) infection and the severity of clinical
signs are a consequence of a complex interrelationship
between the infectious agent, the arthropod vector and
immune response of the dog [2]. Substantial evidence sup-
ports that the spleen plays a key role in the immunopathol-
ogy of CVBD [3]. However, the development of splenic
disease in itself has also been anecdotally associated with
the presence of VBP infections in dogs [4, 5].
The spleen is a secondary lymphoid organ specialized
in filtering blood-borne pathogens and antigens by both
innate and adaptive immune response. The splenic red
pulp contains macrophages that trap and remove
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damaged red blood cells. The blood flow pattern and a
subset of specialized macrophages ensure that the
antigen-presenting cells capture and deliver these blood-
borne antigens to the B cells in the marginal zone. After-
wards, antibody-producing cells migrate from the
primary follicles in the white pulp, colonize the marginal
zone and move into the red pulp, where antibody pro-
duction occurs before blood returning to the circulation
[6]. Further characterization of the immunological phe-
nomena, developed in the spleen of VBP-infected dogs
and other mammals, remains subject of continuous
investigation. The acute splenic response of calves to
Babesia bovis was remarkably similar to that reported in
a mouse model of malarial infection indicating that
dynamic changes in the distribution of splenic cells is
common in the acute response to the hemoparasitic
infection [7]. It was shown that the spleen is able to
retain Bartonella spp. using an experimental mouse
model, although the mechanisms of retention have still
to be elucidated [8]. During the acute phase of experi-
mentally induced canine monocytic ehrlichiosis, high
levels of tumor necrosis factor (TNF)-α expression were
found in splenocytes, CD8+ cells were decreased while
CD3+ cells were increased, which could have occurred
as an immunologic modulation in the spleen contribut-
ing to the pathogenesis. Furthermore, immunohisto-
chemistry revealed a higher number of immunoglobulin
(Ig) M and IgG immunolabeled cells responsible, at least
in part, for the morphological changes observed in this
organ [9, 10].
Several reports have been focused on describing the cel-
lular immunophenotypic profile in the splenic compart-
ment and the co-expression of Th1 pro-inflammatory
cytokines [such as interferon (IFN)-γ, interleukin (IL)-12
and TNF-α] and Th2 anti-inflammatory/regulatory cyto-
kines [such as tumor growth factor (TGF)-β, IL-4 and IL-
10], throughout the course of natural and experimental
visceral leishmaniosis [11, 12]. The large number of cells
(lymphocytes) undergoing apoptosis in the spleen of dogs
with visceral leishmaniosis was correlated with the para-
site load, which suggested that this process could be a
contributing factor for the survival of the protozoon in
this organ [13]. Of note, splenectomy was considered one
of the main clinical outbreaks of hemotropic Mycoplasma
spp. infection in splenectomized dogs [14]. Theileria equi
was found in the spleen of asymptomatic horses that did
not show parasitemia, which suggested that this might be
an important tissue supporting the persistence of the
parasite in the host [15].
On the other hand, VBP infection can induce changes in
the architecture of the spleen. Conditions such as babesiosis
that increase the size of this organ elevate the risk of paren-
chymal disruption [16]. Bartonella spp. infection has been
associated to the presence of granulomatous splenic lesions,
abscess, and vasoproliferative tumors, such as hemangio-
pericytoma and hemangioendothelioma in dog and human
patients, respectively [17–19]. Molecular confirmation sup-
ported higher prevalence for Bartonella spp. compared to
Babesia spp. and hemotropic Mycoplasma spp. in dogs
with fibrohistiocytic nodules (FHN) and hemangiosarcoma
(HSA) in the spleen [4]. Mechanistic evidence as to how
these bacteria contribute to the development of vasoproli-
ferative lesions has been provided [5]. Additionally, splenic
vasculitis, thrombosis and infarction, were recently docu-
mented in a febrile dog diagnosed with Bartonella henselae
[20]. Moreover, a comparative experimental infection study
in dogs infected with Ehrlichia spp. and Anaplasma spp.
described infiltration of perivascular mononuclear cells into
the spleen, more severe for ehrlichial infections [21]. Leish-
mania infantum and Hepatozoon canis were identified in
the spleen of dogs with splenitis [22]; and progressive
spleen architecture breakage in visceral leishmaniosis was
characterized by disorganization of the white pulp, associ-
ated with a more frequent and intense plasma cell accumu-
lation in this organ, mostly in dogs with high parasite
density [23].
The present study aimed to evaluate the prevalence of
certain VBP commonly found in the Mediterranean area,
such as Babesia spp., Bartonella spp., Ehrlichia/Ana-
plasma spp., H. canis, L. infantum, hemotropic Myco-
plasma spp. and Rickettsia spp., in dogs with splenic
disease and to investigate potential associations of these
pathogens with the development of splenic lesions.
Methods
Sample collection
Fresh splenic tissue and/or ethylene diamine tetraacetic
acid (EDTA)-blood samples from dogs undergoing splen-
ectomy in two Referral Veterinary Hospitals located in a
Mediterranean area, were collected and stored immedi-
ately after surgery (-20 °C), between January 2010 and
June 2016. Diagnosis of splenic disease was based on a
combination of clinical signs, laboratory testing, diagnostic
imaging assessment, findings on surgical exploration of
the abdominal cavity, and cytological and/or histopatho-
logical evaluation of the spleen. For 17 cases in which
fresh splenic tissue samples were not collected, available
paraffin-embedded surgical biopsy samples were retrieved
from pathology archive storage facilities, using the Path-
ology Data Base. Although not at the same time, splenic
tissue samples were processed and paraffin-embedded
with the same equipment and techniques. Board-certified
veterinary pathologists performed the histopathological
evaluation of the splenic tissue samples.
Control EDTA-blood samples were prospectively
collected and stored (-20 °C) from dogs with or without
clinical signs attending the hospitals for unrelated rea-
sons during the same period, but whose spleens were
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deemed within normal limits on imaging assessment
(ultrasound and/or computed tomography). All splenic
tissue and EDTA-blood samples were identified and
processed for polymerase chain reaction (PCR).
Signalment was recorded and medical information was
reviewed for every dog. Verbal owner consent was
received for all dogs prior to their enrolment in the
study. This study was carried out in accordance with the
International Guiding Principles for Biomedical Research
Involving Animals, issued by the Council for the Inter-
national Organizations of Medical Sciences.
PCR testing
DNA from splenic tissue was extracted using the Purelink®
Genomic DNA Kit following manufacturer instructions
(Thermo Fisher Scientific, Waltham, MA, USA). DNA
was extracted from 400 μl of whole blood as previously
described [24]. Collected samples, previously defined as
specific pathogen-free (SPF) by PCR, were used as an ex-
traction negative control in each extraction batch. Samples
were tested in an operator blind manner. Babesia spp.,
Bartonella spp., Ehrlichia/Anaplasma spp., H. canis,
hemotropic Mycoplasma spp. and Rickettsia spp. were tar-
geted using specific PCR assays (Table 1). Real time PCR
was carried out in a total volume of 20 μl containing
SYBR® Select master mix (Thermo Fisher Scientific), spe-
cific primer (see Table 1 for sequence and concentration)
and 4 μl of 1/5 diluted DNA. The thermal cycling profile
was 50 °C for 2 min and 95 °C for 10 min followed by
40 cycles at 95 °C for 15 s and 60 °C for 1 min and a dis-
sociation curve added at the end of the run. Water was
used as PCR negative control and commercial DNAs as
positive PCR control. In all cases in which splenic tissue
and EDTA-blood samples were PCR-positive, direct DNA
sequencing was performed to characterize pathogens at
the species level. Sequencing was done by the BigDye®
Terminator v3.1 Cycle Sequencing Kit (Thermo Fisher
Scientific) following the manufacturer instructions and
with the same primers used in the PCR and sequences
compared with the GenBank database (https://blas-
t.ncbi.nlm.nih.gov/Blast.cgi). The eukaryotic 18S riboso-
mal ribonucleic acid (rRNA) (Thermo Fisher Scientific)
was used as an endogenous control to ensure proper
DNA extraction. Quantitative L. infantum PCR was per-
formed as described by Francino and collaborators [24].
Statistical analysis
Statistical analysis was performed using SPSS® 20.0 soft-
ware. Values for the prevalence of Babesia spp., Bartonella
spp., Ehrlichia/Anaplasma spp., H. canis, L. infantum,
hemotropic Mycoplasma spp. and Rickettsia spp. were
established. Chi-square and Fisher’s exact test were used
to compare proportions of positivity. The level of statis-
tical significance considered was P < 0.05.
Results
A total of 138 dogs were enrolled in this study. Additional
file 1: Table S1 shows in detail the signalment, samples
collected, histopathological diagnosis and PCR results.
Seventy-eight dogs were included in the group with
spleen alterations, 40 female (51.94%) and 37 male
(48.05%). Twenty-seven different breeds were repre-
sented including crossbreed dogs (n = 15), German
Shepherd (n = 13), Boxer (n = 6), English Cocker Spaniel
(n = 5), Golden Retriever (n = 4), Beagle (n = 3), French
Bulldog (n = 3), Great Dane (n = 3), Labrador Retriever
(n = 3), and others (n = 22). Age of dogs in this group
ranged from 3 to 16 years, with a mean age of 9 years.
Signalment was partially unknown for four dogs. The
control group included 60 dogs, 35 female (58.3%) and
25 male (41.7%). Twenty-four different breeds were rep-
resented including: crossbreed dogs (n = 14), Yorkshire
Terrier (n = 9), Golden Retriever (n = 5), Boxer (n = 3),
German Shepherd (n = 3), Miniature Schnauzer (n = 3),
and others (n = 23). Age of dogs in this group ranged
from 1 to 16 years, with a mean age of 8.3 years. Histo-
pathology of the spleen was performed in 64 out of 78
dogs with spleen alterations. Benign lesions were
Table 1 PCR targets and primers used in this study for detection of Babesia spp., Bartonella spp., Ehrlichia/Anaplasma spp., H. canis,
hemotropic Mycoplasma spp. and Rickettsia spp.
Species Target
gene
Forward primer (5′–3′) Reverse primer (5′–3′) Final primer
concentration (μM)
Reference
Babesia spp. 18S rRNA GACGATCAGATACCGTCGTAGTCC CAGAACCCAAAGACTTTGATTTCTCTC 0.3 [62]
Bartonella spp. ITS1 AGATGATGATCCCAAGCCTTCTG CCTCCGACCTCACGCTTATCA 0.3 Modified from
[63, 64]
Ehrlichia spp.;
Anaplasma spp.
16S rRNA GCAAGCYTAACACATGCAAGTCG GGATTATACAGTATTACCCAYCATTTCTARTG 0.5 [65, 66]
H. canis 18S rRNA CTTACCGTGGCAGTGACGGT ATTGTTATTTCTTGTTACTACCTCTCTCAAAC 0.3 [66]
Hemotropic
Mycoplasma spp.
16S rRNA ATGTTGCTTAATTCGATAATACACGAAA ACRGGATTACTAGTGATTCCAACTTCAA 0.3/0.5 [65]
Rickettsia spp. ITS2 GCTCGATTGRTTTACTTTGCTGTGAG CATGCTATAACCACCAAGCTAGCAATAC 0.5/0.3 [62]
Abbreviations: rRNA ribosomal ribonucleic acid, ITS internal transcribed spacer
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observed in the 51.56% (33/64). The most common were
lymphoid nodular hyperplasia (LNH) (n = 10), conges-
tion (n = 9), necrosis (n = 7), hematoma (n = 5), extrame-
dullary hematopoiesis (n = 4), and hemosiderosis (n = 3).
Some dogs were histopathologically diagnosed with
more than one benign splenic lesion. Malignant lesions
were observed in the remaining 48.43% (31/64). The
most common was HSA (n = 25), followed by carcinoma
(n = 2), lymphoma (n = 2), FHN (n = 1), and undifferenti-
ated sarcoma (n = 1). Nine out of the 78 dogs with
spleen alterations were diagnosed with splenic torsion,
two with splenic rupture due to a blunt abdominal
trauma, and three were euthanized. The owners refused
further investigation in these 14 cases, so histopatho-
logical assessment of the spleen could not be performed.
PCR was positive for 15 out of 138 dogs included
(10.9%). For dogs with spleen alterations, 13 out of 78
(16.67%) were PCR-positive for at least one VBP when
either splenic tissue (n = 4) or blood (n = 9) was tested.
On the other hand, only 2 out of 60 control dogs (3.3%)
were found PCR-positive for VBP. In the 13 positive
dogs, agreement was not found for PCR outcome
between splenic tissue and EDTA-blood samples ob-
tained from the same dog. PCR results, type of biological
samples analyzed in positive cases, and histopathological
diagnosis of the spleen when it was available, are shown
in Table 2. Statistical analysis revealed that VBP infec-
tion was significantly associated to the presence of
splenic disease (χ2 = 6.223, df = 1, P < 0.05). Relationship
between VBP infection and the character of the splenic
lesions was clinically presumed (χ2 = 0.161, df = 1, P >
0.05). Indeed, all dogs infected with B. canis were diag-
nosed with HSA (χ2 = 7.473, df = 1, P < 0.05).
Discussion
In the study presented here, PCR detected a higher preva-
lence of VBP in dogs with splenic alterations (16.67%) as
compared with dogs without evidence of splenic changes
(3.3%), which supports a potential relationship between
the pathogenesis of CVBD and splenic diseases.
To the best of our knowledge, the literature contains
only one report by Varanat and collaborators on molecu-
lar prevalence of certain VBP in dogs with specific
splenic conditions [4]. In the latter study, Bartonella
spp. DNA was more frequently detected in FHN
(29.7%), HSA (26%) and LNH (10%) compared to Babe-
sia spp. (2.7, 2.0 and 2.0%, respectively) and hemotropic
Mycoplasma spp. (0, 6 and 0%, respectively), while all of
the paraffin-embedded splenic tissues from dogs with
histologically unremarkable spleens were PCR negative
[4]. Differences observed between dogs with splenic dis-
ease and control dogs in the study of Vranat et al. [4]
are in agreement with results obtained here. In contrast,
specific prevalence of infection with Bartonella spp., Ba-
besia spp. and Mycoplasma spp. disagree greatly. Differ-
ences in epidemiological conditions and populations
tested could explain such discrepancy. However, the
absence of Bartonella spp. DNA in dogs with splenic
disease, mainly vasoproliferative tumor-like lesions, was
unexpected in our investigation. Molecular evidence
supports that four species of Bartonella, alone or in co-
infection, could potentially induce vasoproliferative
Table 2 Relationship between histopathological examination of spleen tissue samples and vector-borne pathogens detected
Dog PCR result Sample Hystopathology
S1 Babesia canis Frozen spleen HSA
S2 Babesia canis EDTA-blood HSA
S3 Babesia canis EDTA-blood HSA
S4 Babesia canis EDTA-blood HSA
S5 Babesia gibsoni Paraffin-fixed spleen EH, hemosiderosis, LNH
S6 Babesia gibsoni EDTA-blood Congestion, hematoma
S7 Babesia gibsoni EDTA-blood Congestion
C1 Babesia gibsoni EDTA-blood na
S8 “Babesia vulpes” EDTA-blood na (splenic torsion)
S9 Ehrlichia canis Frozen spleen Congestion, hematoma
C2 Hepatozoon canis EDTA-blood na
S10 Leishmania infantum Frozen spleen EH, myeloid metaplasia
S11 “Candidatus Mycoplasma hemovis” EDTA-blood Congestion, EH, hemosiderosis
S12 Mycoplasma ovis EDTA-blood Carcinoma
S13 Rickettsia massilliae EDTA-blood LNH
Abbreviations: S, dogs with spleen alterations, C, control dogs, EH extramedullary hematopoiesis, HSA hemangiosarcoma, LNH lymphoid nodular hyperplasia, na
not available
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lesions [5]. Bartonella infection induces overlapping
mechanisms in the development of vasoproliferative tu-
mors, such as direct mitogenic effect on endothelial
cells, inhibition of endothelial cell apoptosis and activa-
tion of hypoxia inducible factor-Iα, resulting in increased
expression of the vascular endothelial growth factor
[25–28]. In Spain, serological evidence of Bartonella
spp. exposure and molecular detection of the genera
have been reported in dogs [29–31]. However, diagnosis
of bartonellosis represents a challenge [31] and could be
the main cause of the difference in the prevalence of
Bartonella spp. between the study by Varanat et al. [4]
and the present study. The use of a combined approach
of serology, pre-enrichment culture of Bartonella spp. in
Bartonella alpha proteobacteria growth medium
(BAPGM) and PCR may enhance the diagnostic con-
firmation of bartonellosis in blood or tissue samples of
naturally infected dogs [20, 31, 32].
In contrast, Babesia spp. showed the highest prevalence
in the present survey (6.52%) with nine out of 138 dogs in-
fected. Similar rate of molecular detection for Babesia spp.
in EDTA-blood samples (5%) was reported for dogs from
the same area presenting for compatible clinical signs and/
or criteria with ehrlichiosis during 2011 [33]. The spleen
protects against Babesia spp. by ingestion and clearance of
infected red blood cells [34]. Infected erythrocytes could
alter spleen histopathology, cause cell cycle alteration (G0/
G1, S, and G2/M phases) and induce oxidative stress in
splenic tissue, as indicated by decreased glutathione, cata-
lase and superoxide dismutase levels [35]. Damaged red
blood cells, iron, free radicals and other reactive oxygen
species from macrophage activation produce DNA damage
in endothelial cells [36]. Moreover, once activated, macro-
phages are the main source of growth factors and cytokines
(such as TNF-α, IL-12 and IFN-γ), which profoundly affect
endothelial, epithelial and mesenchymal cells in the local
microenvironment [37–39]. It is now becoming clear that
the tumor microenvironment, which is largely coordinated
by inflammatory cells, is an essential contributor in the
neoplastic process, promoting proliferation, survival and
migration [39]. These phenomena coupled together could
provide the events necessary for the induction of HSA [36].
In the present study, PCR testing identified four dogs
infected with B. canis and, interestingly, all of them were di-
agnosed with HSA. On the other hand, a potential causative
role in the development of splenitis has been attributed to
the presence of mesenchymal neoplastic diseases [22]. As
previously described, HSA could predispose to alter the
splenic vasculature, thrombosis, and abnormal blood flows,
possibly favoring bacterial engraftment [40].
Hemotropic Mycoplasma ovis was PCR-detected in
one out of two dogs diagnosed with splenic carcinoma.
Many studies have indicated that persistent exposure to
Mycoplasma spp. is closely associated with oncogenic
transformation in human cancers and have found that
the Mycoplasma p37 protein alone is sufficient to in-
crease the invasiveness and metastases of cancer cells
[41–44]. Mycoplasma spp. DNA was successfully ex-
tracted and amplified from multiple forms of human
carcinoma [44–46]. Experimental data indicated that
some Mycoplasma spp. cause chromosomal changes and
cell transformations in vitro through progressive
chromosomal loss and translocations. However, the rela-
tionship between Mycoplasma spp. infection and cancer
progression is yet to be disclosed [45].
Evidence supports that infiltration and activation of
inflammatory cells confer favorable conditions for the
progression of cancer, inducing angiogenesis, tumor
growth and invasion [46]. To elucidate whether VBP
induce such infiltration and activation of inflammatory
cells in the spleen or alternatively are attracted to pre-
existing neoplastic splenic inflammatory lesions, thereby
explaining DNA detection of VBP in these dogs, war-
rants further investigation.
Remaining VBP infected dogs showed benign splenic
diseases or were control dogs. Four of these were in-
fected with B. gibsoni. In contrast to reported data,
breed predisposition was not observed for this infection
[47]. Histopathology was not available for the only “B.
vulpes”-infected dog that was diagnosed with splenic
torsion associated with gastric-dilation volvulus (GDV).
Evidence supports that “B. vulpes” is genetically related
to B. gibsoni [48]. Trotta et al. [49] described a B. gib-
soni-infected dog with suspected splenic torsion. In such
case, histopathological evaluation of the spleen revealed
white and red pulp hyperplasia, associated with a diffuse
granulocytic infiltrate, hemorrhages and massive necro-
sis with vascular thrombosis, suggestive of splenic infarct
[49]. In addition, a dog with splenic torsion and PCR
positive for L. infantum was also reported [22]. In this
case, the authors considered that both conditions might
have triggered splenitis because of altered vascularity
and blood supply or activation of the reticuloendothelial
system. The etiology of primary splenic torsion (PST)
and the association between PST and GDV is unclear,
with anecdotal evidence suggesting that dogs with his-
tory of PST have an increased risk of developing GDV
[50]. Based on the former information, we hypothesize
that in the dog of the present study splenic changes as-
sociated with VBP infection could have induced PST,
and potentially secondary GDV.
Anaplasma spp. was not detected in any dog. Further-
more, in the present study, prevalence of Ehrlichia canis,
L. infantum, H. canis and Rickettsia massilliae was lower
than expected given previous reports conducted in the
same area [29, 30]. These findings combined, suggest that
these pathogens may be underestimated in the current
study. As previously described, several factors could
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prompt failure to reach PCR diagnosis, such as small
quantity of tissue placed in paraffin blocks from markedly
enlarged spleens and the limited quantity of extracted
DNA (host and pathogen) that can be incorporated into
each PCR reaction, storage conditions and varying periods
of formalin fixation that could induce DNA degradation,
and/or decreased microorganism load in systemic circula-
tion, possibly associated with the use of specific treatment
before obtaining the samples [4, 31, 51].
Serological and PCR assays used in parallel could have
maximized CVBD diagnosis [52]. However, in agreement
with previous publications, the results obtained in blood
and tissue samples from dogs with spleen alterations sup-
port that sampling from different tissues improved detec-
tion of VBP infection [53–56]. The tropism of certain
VBP, such as L. infantum caused by lymphoid organs
makes them important for detecting this protozoan [56].
It has been shown that positivity increases with disease
progression and dogs without clinical signs present lower
tissue parasitism, while dogs with clinical signs have high
parasite loads in tissues such as the spleen [57]. Moreover,
parasites do not distribute themselves evenly in all tissues
[58]. Several parameters should be considered in choosing
the sample to be used with special care to avoid excessive
invasiveness and potential risks for the dog, such as pain,
infection or hemorrhage [59].
None of the PCR-positive dogs in the present study
showed VBP infection on histopathology of the spleen.
As previously described, it is possible that some splenic
macrophages had phagocytosed DNA fragments, but in-
tact microorganisms were not detectable, so the amplifi-
cation methods used with PCR allowed positive results
with very small amounts of DNA, while this was not
achievable by means of histopathology [22].
There were some limitations in the present study, which
have still to be mentioned. Due to the partially retrospect-
ive nature of this research and the fact that dogs attended
at different institutions, information gathered from avail-
able medical records was sometimes incomplete. Further-
more, obtaining optimal age and sex-matched groups was
not entirely possible because splenectomy is performed
only when there is overt evidence of splenic alterations
and splenic biopsies are infrequently obtained. In addition,
it is not possible to rule out differences in the processing
of the paraffin-embedded tissue samples, retrieved from
the pathology archive storage facilities, which were
obtained before the frozen-samples collection period.
Moreover, control dogs without evidence of splenic alter-
ations were selected based on diagnostic imaging assess-
ment; although ultrasonography and/or radiological
splenic changes have shown a good correlation with other
laboratory examinations in CVBD, histopathology could
have been useful to further confirm the absence of splenic
disease in such cases [60, 61]. In addition, samples were
stored and retrieved from archives, so prior contamination
could not be completely excluded.
Conclusions
This study provides additional evidence that CVBD
could be involved in the pathogenesis of splenic alter-
ations. The high prevalence of B. canis infection in dogs
with splenic HSA suggests a potential role for this
pathogen in the development of vasoproliferative tu-
mors. Furthermore, based on the results obtained here,
the presence of splenic disease should prompt further
investigation for detection of VBP infection, mainly in
endemic areas. Detection of VBP infection is improved
by sampling of different tissues.
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